The nitric oxide-cyclic GMP pathway is required for nociceptive signalling at specific loci within the somatosensory pathway

Neuroscience

Volumn 73, Issue 3, 1996, Pages 649-655

  Salter, M ^a,b   Strijbos, P J L M ^a,c   Neale, S ^a,b   Duffy, C ^a,b   Follenfant, R L ^a   Garthwaite, J ^a,c  

^a WELLCOME RESEARCH LABORATORIES   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

L NAME; nitric oxide synthase; ODQ; pain; rat somatosensory pathway

Indexed keywords

1,2,4 OXADIAZOLE DERIVATIVE; 1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; CYCLIC GMP; GUANYLATE CYCLASE INHIBITOR; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; QUINOXALINE DERIVATIVE; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG THERAPY; ENZYME ACTIVITY; ENZYME INHIBITION; HYPERALGESIA; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRATHECAL DRUG ADMINISTRATION; MALE; NERVE LIGATION; NOCICEPTION; NONHUMAN; PERIPHERAL NEUROPATHY; PREVENTION; PRIORITY JOURNAL; RAT; SOMATOSENSORY SYSTEM; SURAL NERVE; SYNAPTIC TRANSMISSION; THERMAL STIMULATION;

EID: 0030218947     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-4522(96)00060-7     Document Type: Article

References (39)

1. ω-nitro-L-arginine methyl ester of the electrocortical arousal response in rats. Br. J. Pharmac. 108, 858-860.
2. 2. Bennett G. J. and Xie Y.-K. (1988) A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33, 87-107.
3. 3. Boulton C. L., Southam E. and Garthwaite J. (1995) Nitric oxide-dependent long-term potentiation is blocked by a specific inhibitor of soluble guanylyl cyclase. Neuroscience 69, 699-703.
4. 4. Crosby G., Marota J. J. A. and Huang P. L. (1995) Intact nociception-induced neuroplasticity in transgenic mice deficient in neuronal nitric oxide synthase. Neuroscience 69, 1013-1017.
5. 5. Cudeiro J., Rivadulla C., Rodriguez R., Martinez-Conde S., Acuñ C. and Alonso J. M. (1994) Modulatory influence of putative inhibitors of nitric oxide synthase on visual processing in the cat lateral geniculate nucleus. J. Neurophysiol. 71, 146-149.
6. 6. Dun N. J., Dun S. L., Forstermann U. and Tseng L. F. (1992) Nitric oxide immunoreactivity in rat spinal cord. Neurosci. Lett. 147, 217-220.
7. 7. Garry M. G., Durnett Richardson J. and Hargreaves K. M. (1994) Carrageenan-induced inflammation alters the content of i-cGMP and i-cAMP in the dorsal horn of the spinal cord. Brain Res. 646, 135-139.
8. 8. Garthwaite J. (1993) Nitric oxide signalling in the central nervous system. Semin. Neurosci. 5, 171-180.
9. 9. Garthwaite J., Southam E., Boulton C. L., Nielson E. B., Schmidt K. and Mayer B. (1995) Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one. Molec. Pharmac. 48, 184-188.
10. 10. Hargreaves K., Dubner R., Brown F., Flores C. and Joris J. (1988) A new and sensitive method for measuring thermal nociception in cutaneous analgesia. Pain 32, 87-107.
11. 11. Huang P. L., DawsonT. M., Bredt D. S., Snyder S. H. and Fishman M. C. (1993) Targeted disruption of the neuronal nitric oxide synthase gene. Cell 75, 1273-1286.
12. 12. Izumi Y. and Zorumski C. F. (1993) Nitric oxide and long-term synaptic depression in the rat hippocampus. Neuroreport 4, 1131-1134.
13. 13. Kapás L., Fang J. and Krueger J. M. (1994) Inhibition of nitric oxide synthesis inhibits rat sleep. Brain Res. 664, 189-196.
14. 14. Kawabata A., Umeda N. and Takagi H. (1993) L-Arginine exerts a dual role in nociceptive processing in the brain: involvement of the kyotorphin-Met-enkephalin pathway and NO-cyclic GMP pathway. Br. J. Pharmac. 109, 73-79.
15. 15. Kitto K. F., Haley J. E. and Wilcox G. L. (1992) Involvement of nitric oxide in spinally mediated hyperalgesia in the mouse. Neurosci. Lett. 148, 1-5.
16. 16. Knowles R. G. and Moncada S. (1994) Nitric oxide synthases in mammals. Biochem. J. 298, 249-258.
17. 17. Li J. and Iadecola C. (1994) Nitric oxide and adenosine mediate vasodilation during functional activation in cerebellar cortex. Neuropharmacology 33, 1453-1462.
18. 18. Linden D. J. (1994) Long-term synaptic depression in the mammalian brain. Neuron 12, 457-472.
19. 19. Malmberg A. B. and Yaksh T. L. (1993) Spinal nitric oxide synthesis inhibition blocks NMDA-induced thermal hyperalgesia and produces antinociception in the formalin test in rats. Pain 54, 291-300.
20. 20. Meiler S. T., Pechman P. S., Gebhart G. F. and Maves T. J. (1992) Nitric oxide mediates the thermal hyperalgesia produced in a model of neuropathic pain in the rat. Neuroscience 50, 7-10.
21. 21. Meiler S. T., Dykstra C. and Gebhart G. F. (1992) Production of endogenous nitric oxide and activation of soluble guanylate cyclase are required for NMDA-produced facilitation of the nociceptive tail-flick reflex. Eur. J. Pharmac. 214, 93-96.
22. 22. Meiler S. T. and Gebhart G. F. (1993) Nitric oxide (NO) and nociceptive processing in the spinal cord. Pain 52, 127-136.
23. 23. Meiler S. T., Cummings C. P., Traub R. J. and Gebhart G. F. (1994) The role of nitric oxide in the development and maintenance of the hyperalgesia produced by intraplantar injection of carageenan in the rat. Neuroscience 60, 367-374.
24. 24. Moncada S. and Higgs E. A. (1993) The L-arginine-nitric oxide pathway. New Engl. J. Med. 329, 2002-2012.
25. G-Nitro arginine methyl ester exhibits antinociceptive activity in the mouse. Br. J. Pharmac. 102, 198-202.
26. 26. Moore P. K., Babbedge R. C., Wallace P., Geflen Z. A. and Hart S. L. (1993) 7-Nitro indazole. an inhibitor of nitric oxide synthase, exhibits anti-nociceptive activity in the mouse without increasing blood pressure. Br. J. Pharmac. 108, 296-297.
27. 27. Morris R., Southam E., Gittins S. R., de Vente J. and Garthwaite J. (1994) The NO-cGMP pathway in neonatal rat dorsal horn. Eur. J. Neurosci. 6, 876-879.
28. 28. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press, New York.
29. 29. Rees D. D., Palmer R. M. J., Schulz R., Hodson H. F. and Moncada S. (1990) Characterisation of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br. J. Pharmac. 101, 746-752.
30. 2+-independent nitric oxide synthases. Fedn Eur. biochem. Socs Lett. 291, 145-149.
31. 31. Salter M., Duffy C. and Hazelwood R. (1995) Determination of brain nitric oxide synthase inhibition in vivo: ex vivo assays of nitric oxide synthase can give incorrect results. Neuropharmacology 34, 327-334.
32. ω-nitro-L-arginine (L-NA) and its methyl ester (L-NAME). Neuropharmacology 34, 639-649.
33. 33. Salter M., Duffy C., Garthwaite J. and Strijbos P. J. L. M. (1996) Ex vivo measurement of brain tissue nitrite and nitrate accurately reflects nitric oxide synthase activity in vivo. J. Neurochem. 66, 1683-1690.
34. 34. Schuman E. M. and Madison D. V. (1994) Locally distributed synaptic potentiation in the hippocampus. Science 263, 532-536.
35. 35. Steel J. H., Terenghi G., Mo Chung J., Sik Na H., Carlton S. M. and Polak J. M. (1994) Increased nitric oxide synthase immunoreactivity in rat dorsal root ganglia in a neuropathic pain model. Neurosci. Lett. 169, 81-84.
36. 36. Valtschanoff J. G., Weinberg R. J. and Rustioni A. (1992) NADPH diaphorase in the spinal cord of rats. J. comp. Neurol. 321, 209-222.
37. 37. Verge V. M., Xu Z., Xu X.-J., Wiesenfeld-Hallin Z. and Hokfelt T. (1992) Marked increase in nitric oxide synthase mRNA in dorsal root ganglia after peripheral axotomy: in situ hybridization and functional studies. Proc. natn. Acad. Sci. U.S.A. 89, 11617-11621.
38. 38. Vizzard M. A., Erdman S. L. and de Groat W. C. (1995) Increased expression of neuronal nitric oxide synthase in dorsal root ganglion neurons after systemic capsaicin administration. Neuroscience 67, 1-5.
39. 39. Yaksh T. L. and Rudy T. A. (1976) Chronic catheterisation of the spinal subarachnoid space. Physiol. Behav. 17, 1031-1036.